Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection

Abstract Chagas disease resulting from Trypanosoma cruzi infection leads to a silent, long-lasting chronic neglected tropical disease affecting the poorest and underserved populations around the world. Antiparasitic treatment with benznidazole does not prevent disease progression or death in patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julio V. Cruz-Chan, Liliana E. Villanueva-Lizama, Leroy Versteeg, Ashish Damania, Maria José Villar, Cristina González-López, Brian Keegan, Jeroen Pollet, Fabian Gusovsky, Peter J. Hotez, Maria Elena Bottazzi, Kathryn M. Jones
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7d8ab2248bad4bc78f23356c1341a291
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7d8ab2248bad4bc78f23356c1341a291
record_format dspace
spelling oai:doaj.org-article:7d8ab2248bad4bc78f23356c1341a2912021-12-02T14:06:11ZVaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection10.1038/s41598-021-82930-w2045-2322https://doaj.org/article/7d8ab2248bad4bc78f23356c1341a2912021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82930-whttps://doaj.org/toc/2045-2322Abstract Chagas disease resulting from Trypanosoma cruzi infection leads to a silent, long-lasting chronic neglected tropical disease affecting the poorest and underserved populations around the world. Antiparasitic treatment with benznidazole does not prevent disease progression or death in patients with established cardiac disease. Our consortium is developing a therapeutic vaccine based on the T. cruzi flagellar—derived antigen Tc24-C4 formulated with a Toll-like receptor 4 agonist adjuvant, to complement existing chemotherapy and improve treatment efficacy. Here we demonstrate that therapeutic treatment of acutely infected mice with a reduced dose of benznidazole concurrently with vaccine treatment – also known as “vaccine-linked chemotherapy”—induced a TH17 like immune response, with significantly increased production of antigen specific IL-17A, IL-23 and IL-22, and CD8 + T lymphocytes, as well as significantly increased T. cruzi specific IFNγ-producing CD4 + T lymphocytes. Significantly reduced cardiac inflammation, fibrosis, and parasite burdens and improved survival were achieved by vaccine-linked chemotherapy and individual treatments. Importantly, low dose treatments were comparably efficacious to high dose treatments, demonstrating potential dose sparing effects. We conclude that through induction of TH17 immune responses vaccine-linked chemotherapeutic strategies could bridge the tolerability and efficacy gaps of current drug treatment in Chagasic patients.Julio V. Cruz-ChanLiliana E. Villanueva-LizamaLeroy VersteegAshish DamaniaMaria José VillarCristina González-LópezBrian KeeganJeroen PolletFabian GusovskyPeter J. HotezMaria Elena BottazziKathryn M. JonesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Julio V. Cruz-Chan
Liliana E. Villanueva-Lizama
Leroy Versteeg
Ashish Damania
Maria José Villar
Cristina González-López
Brian Keegan
Jeroen Pollet
Fabian Gusovsky
Peter J. Hotez
Maria Elena Bottazzi
Kathryn M. Jones
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
description Abstract Chagas disease resulting from Trypanosoma cruzi infection leads to a silent, long-lasting chronic neglected tropical disease affecting the poorest and underserved populations around the world. Antiparasitic treatment with benznidazole does not prevent disease progression or death in patients with established cardiac disease. Our consortium is developing a therapeutic vaccine based on the T. cruzi flagellar—derived antigen Tc24-C4 formulated with a Toll-like receptor 4 agonist adjuvant, to complement existing chemotherapy and improve treatment efficacy. Here we demonstrate that therapeutic treatment of acutely infected mice with a reduced dose of benznidazole concurrently with vaccine treatment – also known as “vaccine-linked chemotherapy”—induced a TH17 like immune response, with significantly increased production of antigen specific IL-17A, IL-23 and IL-22, and CD8 + T lymphocytes, as well as significantly increased T. cruzi specific IFNγ-producing CD4 + T lymphocytes. Significantly reduced cardiac inflammation, fibrosis, and parasite burdens and improved survival were achieved by vaccine-linked chemotherapy and individual treatments. Importantly, low dose treatments were comparably efficacious to high dose treatments, demonstrating potential dose sparing effects. We conclude that through induction of TH17 immune responses vaccine-linked chemotherapeutic strategies could bridge the tolerability and efficacy gaps of current drug treatment in Chagasic patients.
format article
author Julio V. Cruz-Chan
Liliana E. Villanueva-Lizama
Leroy Versteeg
Ashish Damania
Maria José Villar
Cristina González-López
Brian Keegan
Jeroen Pollet
Fabian Gusovsky
Peter J. Hotez
Maria Elena Bottazzi
Kathryn M. Jones
author_facet Julio V. Cruz-Chan
Liliana E. Villanueva-Lizama
Leroy Versteeg
Ashish Damania
Maria José Villar
Cristina González-López
Brian Keegan
Jeroen Pollet
Fabian Gusovsky
Peter J. Hotez
Maria Elena Bottazzi
Kathryn M. Jones
author_sort Julio V. Cruz-Chan
title Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
title_short Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
title_full Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
title_fullStr Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
title_full_unstemmed Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
title_sort vaccine-linked chemotherapy induces il-17 production and reduces cardiac pathology during acute trypanosoma cruzi infection
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7d8ab2248bad4bc78f23356c1341a291
work_keys_str_mv AT juliovcruzchan vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT lilianaevillanuevalizama vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT leroyversteeg vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT ashishdamania vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT mariajosevillar vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT cristinagonzalezlopez vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT briankeegan vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT jeroenpollet vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT fabiangusovsky vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT peterjhotez vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT mariaelenabottazzi vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
AT kathrynmjones vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection
_version_ 1718392029843554304